Abstract #3815
Spectroscopic imaging with hyperpolarized [1- 13 C]pyruvate shows an elevated lactate/pyruvate ratio in contrast enhancing and non-enhancing brain tumors of orthotopic patient-derived xenograft models of glioblastoma.
Richard Mair 1,2 , Alan Wright 1 , Kieren Allinson 3 , Tiago Rodrigues 1 , Colin Watts 2 , and Kevin Brindle 1
1
CRUK Cambridge Institute, University of
Cambridge, Cambridge, Cambridgeshire, United Kingdom,
2
Division
of Neurosurgery, University of Cambridge, Cambridge,
Cambridgeshire, United Kingdom,
3
Department
of Pathology, Cambridge University Hospitals NHS
Foundation Trust, Cambridgeshire, United Kingdom
Glioblastoma is the most common
human-primary-intracranial neoplasm and has the worst
prognosis. Novel orthotopic patient-derived xenograft
models that recapitulate the pathophysiological
phenotype of the disease allow development of novel
imaging modalities for downstream clinical applications
in treatment planning and monitoring. We demonstrate
that
13
C
magnetic resonance spectroscopic imaging with
hyperpolarized [1-
13
C]pyruvate shows the
presence of tumor through an elevated lactate/pyruvate
ratio in both contrast enhancing and non-enhancing brain
tumor lesions including areas where tumor is
undetectable on T
2
weighted MRI but present on
histology.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
